Emeryville cancer drug developer lands $21M from Chinese, other investors
September 24, 2014 at 13:37 PM EDT
Cancer therapy developer Eureka Therapeutics Inc. snagged $21 million in a Series C round led by Chinese private equity firm Yuan Capital...